Yun Zhong

Analyst Yun Zhong works at BTIG and is focused on the Healthcare sector with 51 price targets and ratings documented since 2018 spanning on 12 stocks. Previously, Yun Zhong worked at BERENBERG, JANNEY. Analyst's average stock valuation to be materialised ratio is 26.39% with an average time for price targets to be met of 63.88 days.

Most recent stock forecast was given on TSHA, Taysha Gene Therapies Inc. at 02-Feb-2023.

Yun Zhong best performing recommendations are on QURE (UNIQURE N.V).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS, INC) at 11/11/2020. The price target of $140 was fulfilled within 2 days with a profit of $5.27 (3.91%) receiving and performance score of 19.56.

Average potential price target upside

• of $31.82 (33.72%) on SRPT (SAREPTA THERAPEUTICS, INC).
• of $8.27 (27.64%) on QURE (UNIQURE N.V).
• of $0.85 (3.89%) on FOLD (AMICUS THERAPEUTICS, INC).